Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities Using International Pharmacovigilance Database

NCT05349383 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT05349383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05349383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities Using International Pharmacovigilance Database
Lead sponsor
Central South University
Phase
Observational
Overall status
Completed
Start date
April 22, 2022
Completion date
June 1, 2022
Enrollment
24,618 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agranulocytosis, opportunistic infections, sepsis (smq)